Approximately half of PCD cases are related to anti-Yo antibodies and other autoantibodies, including anti-Hu, anti-Ri, anti-Tr, anti-Ma2, anti-P/Q-type VGCC, and anti-CV2/CRMP5 antibodies [212,218,219]. Here, DPYSL5 is linked to paraneoplastic neurologic syndrome.